Revelation Biosciences In...

2.74
0.14 (5.38%)
At close: Apr 02, 2025, 3:49 PM
2.51
-8.39%
After-hours: Apr 02, 2025, 07:12 PM EDT

Revelation Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash & Equivalents 6.5M 11.99M 5.25M 1.27M 4.49M n/a
Short-Term Investments 6.49B n/a n/a n/a 525.29K n/a
Long-Term Investments n/a n/a n/a n/a 73.51M n/a
Other Long-Term Assets 56.28M n/a n/a 0.00 n/a 22.67K
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 66.7M 100.61K 160.3K 148.73K n/a n/a
Total Current Assets 6.57B 12.15M 5.41M 1.91M 4.62M n/a
Property-Plant & Equipment 56.33K 65.08K 90.13K 130.14K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 56.33M 65.08K 90.13K 130.14K 73.51M 22.67K
Total Assets 6.62B 12.21M 5.5M 2.04M 4.62M 22.67K
Account Payables 783.62K 1.36M 554.21K 596.26K 865.9K n/a
Deferred Revenue n/a n/a 2.91M n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a n/a n/a
Other Current Liabilities 1.13M 3.44M 3.28M 771.94K n/a 26.31K
Total Current Liabilities 1.91M 5.56M 4.45M 2.14M 1.21M 26.31K
Long-Term Debt n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a n/a 554.21K 2.91M 2.91M n/a
Total Liabilities 1.91B 5.56M 4.45M 2.14M 1.21M 26.31K
Total Debt n/a n/a n/a 16.75K n/a n/a
Common Stock 522.00 265.00 683.00 2.31K 2.29K n/a
Retained Earnings -40.51B -25.47M -25.35M -14.52M -2.53M -3.64K
Comprehensive Income n/a -0.00 n/a -0.00 n/a n/a
Shareholders Equity 4.71B 6.65M 1.05M -99.47K 3.41M -3.64K
Total Investments 6.49B n/a n/a n/a 525.29K n/a